Authorizations During Emergencies
Pfizer and BioNTech will submit an emergency use authorization request for their jointly-developed COVID-19 vaccine on Friday, the companies announced, in a press release.
Earlier this week, Pfizer said a final analysis of clinical trial data showed the shot is 95% effective.
"Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally," Pfizer CEO Albert Bourla remarked. "Filing in the US repre
Why read sci-fi when we’re living it?